|
Q4 FY2021
As of Sep 30, 2021
|
Q3 FY2021
As of Jun 30, 2021
|
Q2 FY2021
As of Mar 31, 2021
|
Q1 FY2021
As of Dec 31, 2020
|
Q4 FY2020
As of Sep 30, 2020
|
Q3 FY2020
As of Jun 30, 2020
|
Q2 FY2020
As of Mar 31, 2020
|
Q1 FY2020
As of Dec 31, 2019
|
Q4 FY2019
As of Sep 30, 2019
|
Q3 FY2019
As of Jun 30, 2019
|
Q2 FY2019
As of Mar 31, 2019
|
Q1 FY2019
As of Dec 31, 2018
|
Q4 FY2018
As of Sep 30, 2018
|
Q3 FY2018
As of Jun 30, 2018
|
Q2 FY2018
As of Mar 31, 2018
|
Q1 FY2018
As of Dec 31, 2017
|
Q4 FY2017
As of Sep 30, 2017
|
Q3 FY2017
As of Jun 30, 2017
|
Q2 FY2017
As of Mar 31, 2017
|
Q1 FY2017
As of Dec 31, 2016
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investments | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted Cash, Current | ||||||||||||||||||||
| Accounts receivable, allowance | ||||||||||||||||||||
| Trade accounts receivable, net of allowances of $25.4 and $25.9 as of September 30, 2021 and 2020 | ||||||||||||||||||||
| Inventory Valuation Reserves | ||||||||||||||||||||
| Inventory, Net | ||||||||||||||||||||
| Inventory, Finished Goods, Net of Reserves | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment | ||||||||||||||||||||
| Less accumulated depreciation | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Intangible assets: | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets and software, net | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Trade accounts payable | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Accrued product warranties | ||||||||||||||||||||
| Accrued rebates | ||||||||||||||||||||
| Deferred Revenue | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Accrued pension and postretirement benefits | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Preferred stock, authorized (in shares) | ||||||||||||||||||||
| Common stock, authorized (in shares) | ||||||||||||||||||||
| Common stock, issued (in shares) | ||||||||||||||||||||
| Common Stock, Shares, Outstanding | ||||||||||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Capital Stock: | ||||||||||||||||||||
| Common stock - without par value: Authorized - 199,000,000; Issued - 88,457,634 shares in 2017 and 2016 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury Stock, Common, Shares | ||||||||||||||||||||
| Treasury stock, common shares at cost: 22,563,832 as of September 30, 2021 and 21,816,802 as of September 30, 2020 | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | ||||||||||||||||||||
| Total Liabilities and Shareholders' Equity | ||||||||||||||||||||
Loading...
